Third Rock Ventures IV L.P. 13D and 13G filings for Tango Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-04 8:45 pm Sale | 2024-08-30 | 13D | Tango Therapeutics, Inc. TNGX | Third Rock Ventures IV L.P. | 17,001,475 15.900% | -2,362,500 (-12.20%) | Filing |
| 2021-08-19 4:35 pm Purchase | 2021-08-10 | 13D | Tango Therapeutics, Inc. TNGX | Third Rock Ventures IV L.P. | 19,363,975 22.100% | 19,363,975 (New Position) | Filing |